Yovaninna Alarcón‐Soto

Also affiliated with Hospital Universitari Germans Trias i Pujol, Fundació Lluita contra les Infeccions

Immunology and MicrobiologyMedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial”.

Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial

Nature Medicine(2022)10.1038/s41591-022-02060-2

N/A

1.2DataRank · unranked

72 citations

Anuska Llano, Samandhy Cedeño, Tuixent Escribà, Míriam Rosás-Umbert, Mariona Parera +34 more

Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae530

N/A

0DataRank · unranked

12 citations

María C. Puertas, Maria C. García-Guerrero, Igor Moraes-Cardoso, Ester Aparicio, Yovaninna Alarcón‐Soto +31 more

Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy

PLoS Pathogens(2025)10.1371/journal.ppat.1013466

N/A

0DataRank · unranked

5 citations

Lucía Bailón, Víctor Urrea, Maria C. García-Guerrero, Yovaninna Alarcón‐Soto, Àngel Rivero +5 more

Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf545

N/A

0DataRank · unranked

3 citations

Yovaninna Alarcón‐Soto, Àngel Rivero, Pep Coll, Jorge Saz, Michael Meulbroek +11 more

Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._

Communications Medicine(2025)10.1038/s43856-025-01266-y

N/A

0DataRank · unranked

1 citations

Yovaninna Alarcón‐Soto, José Ramón Arribas, Adrián Curran, Anuska Llano, Samandhy Cedeño +11 more

Predictors of virological outcomes after analytical interruption of antiretroviral therapy following immune interventions with HTI vaccines in early-treated people with HIV: a pooled analysis from the AELIX-002 and AELIX-003 clinical trials

Research Square(2025)10.21203/rs.3.rs-6567488/v1

N/A

0DataRank · unranked

0 citations

Yovaninna Alarcón‐Soto, José Ramón Arribas, Adrián Curran, Anuska Llano, Samandhy Cedeño +11 more

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)

Frontiers in Immunology(2020)10.3389/fimmu.2020.00823

N/A

0DataRank · unranked

87 citations

Míriam Rosás-Umbert, Pep Coll, Christian Manzardo, María C. Puertas, Sara Morón‐López +24 more

Impact of Dolutegravir plus Lamivudine as First-Line Antiretroviral Treatment on HIV-1 Reservoir and Inflammatory Markers in Peripheral Blood

UNC Libraries(2025)10.17615/r0t8-mm19

N/A

0DataRank · unranked

0 citations

Yovaninna Alarcón‐Soto, Maria C. García-Guerrero, Lucía Bailón, Àngel Rivero, Beatriz Mothe +9 more